对APDS的死亡率和生存率进行系统审查
Jennifer Hanson1, Penelope E Bonnen2
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Clinical and experimental medicine
|January 27, 2024
概括
活性酸3-酶三角综合征 (APDS) 缩短了寿命,淋巴瘤是导致死亡的主要原因. 新的治疗方法对于改善这种原发性免疫缺陷的存活率至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 活性酸3-酶三角综合征 (APDS) 是一种罕见的原发性免疫缺陷,其特征是复发性感染,淋巴增殖,自身免疫力和癌症风险增加.
- APDS是由影响PI3-激酶通路的PIK3CD (APDS1) 或PIK3R1 (APDS2) 中自体主导变异引起的.
- 现有的治疗方法无法完全缓解与APDS相关的寿命缩短.
研究的目的:
- 分析APDS患者的生存率和死亡率数据.
- 确定APDS中死亡的主要原因.
- 突出需要改进治疗策略的需要.
主要方法:
- 文献审查确定了256名分子诊断APDS的个人 (193 APDS1,63 APDS2).
- 进行了卡普兰-梅尔生存分析.
- 系统地审查了死亡原因.
主要成果:
- 与一般人群相比,APDS患者的生存时间明显缩短.
- 在20,30,40和50岁的条件生存率分别为87%,74%,68%和68%.
- 淋巴瘤 (47.6%) 是主要的死亡原因,其次是HSCT并发症 (15.6%).
结论:
- 与APDS相关的显著死亡率凸显了迫切需要新的治疗策略.
- 针对淋巴瘤和其他癌症,以及管理感染,对于改善APDS患者的治疗结果至关重要.
- 对有效治疗方法的进一步研究对于提高APDS患者的长期存活率至关重要.
相关概念视频
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Assumptions of Survival Analysis
128
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
128
Kaplan-Meier Approach
141
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
141
Introduction To Survival Analysis
239
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
239


